Name: HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC
Brand: MBL Life Sciences
Availability: InStock

Related products

Shop all

HLA-A*02:01 Negative Tetramer-PEMBL Life Sciences$1,610.00

HLA-A*02:01 Negative Tetramer-APCMBL Life Sciences$1,726.00

HLA-A*02:01 Negative Tetramer-BV421MBL Life Sciences$1,726.00

Reviews 0

No reviews have been added for this product.

Reviews

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications
Application	FC
Reactivity	Human
Conjugation	APC
Immunogen	CMV pp65
Peptide Sequence	NLVPMVATV
Class	Class I
Sequence Location	495-503
MHC Allele	A*02:01

Documents & Links for HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC
Datasheet	HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC Datasheet

Documents & Links for HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC
Datasheet	HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC Datasheet

Citations for HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC – 2 Found

Sabouri, Amir H; Usuku, Koichiro; Hayashi, Daisuke; Izumo, Shuji; Ohara, Yoshiro; Osame, Mitsuhiro; Saito, Mineki. Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. Blood. 2008;112(6):2411-20. PubMed

Watanabe, Kazue; Suzuki, Susumu; Kamei, Michi; Toji, Shingo; Kawase, Takakazu; Takahashi, Toshitada; Kuzushima, Kiyotaka; Akatsuka, Yoshiki. CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy. International Journal Of Hematology. 2008;88(3):311-320. PubMed

Reviews 0

Reviews

HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC

Additional information

Reviews 0

HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC

Additional information

Specifications

Specifications

HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC

Additional information

HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC

Additional information

Specifications

Specifications